Feasibility of Eradication of Breast Cancer Cells Remaining in Postlumpectomy Cavity and Draining Lymph Nodes following Intracavitary Injection of Radioactive Immunoliposomes-Reference-Cited by-同舟云学术

Feasibility of Eradication of Breast Cancer Cells Remaining in Postlumpectomy Cavity and Draining Lymph Nodes following Intracavitary Injection of Radioactive Immunoliposomes

Published:2012-08-23 Issue:9 Volume:9 Page:2513-2522
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Li Shihong¹,Goins Beth¹,Hrycushko Brian A.¹,Phillips William T.¹,Bao Ande¹

Affiliation:

1. Department of Radiology and ‡Department of Otolaryngology—Head and Neck Surgery, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229-3900, United States

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/mp300132f

Reference50 articles.

1. Effects of Radiotherapy and Surgery in Early Breast Cancer — An Overview of the Randomized Trials

2. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial

3. 10-Year Results After Sector Resection With or Without Postoperative Radiotherapy for Stage I Breast Cancer: A Randomized Trial

4. Adjuvant radiotherapy for breast cancer: effects of longer follow-up

5. Radiotherapy after breast-conserving surgery in small breast carcinoma: Long-term results of a randomized trial

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitroefficacy andin vivotoxicity and retention of targeted nanoformulated carboplatin in a sustained release carrier for treatment of osteosarcoma;2024-05-05

2. Physicochemical Stimulus-Responsive Systems Targeted with Antibody Derivatives;Current Molecular Medicine;2023-08-18

3. Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook;Pharmaceutics;2023-06-23

4. Recent progress in synthesis of nano based liposomal drug delivery systems: A glance to their medicinal applications;Results in Surfaces and Interfaces;2023-05

5. The Construction of Immunoliposomes (Review);Drug development & registration;2022-08-30